Literature DB >> 7216417

Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers.

B R Murphy, M B Rennels, R G Douglas, R F Betts, R B Couch, T R Cate, R M Chanock, A P Kendal, H F Maassab, S Suwanagool, S B Sotman, L A Cisneros, W C Anthony, D R Nalin, M M Levine.   

Abstract

Two attenuated influenza A donor viruses, the A/Udorn/72 ts-1A2 and the A/Ann Arbor/6/60 cold-adapted (ca) viruses, are being evaluated for their ability to reproducibly attenuate each new variant of influenza A virus to a specific and desired level by the transfer of one or more attenuating genes. Each of these donor viruses has been able to attenuate influenza A viruses belonging to the H3N2 subtype by the transfer of one or more attenuating genes. To determine whether these two donor viruses could attenuate a wild-type virus that belonged to a different influenza A subtype, ts-1A2 and ca recombinants of a wild-type virus representative of the A/USSR/77 (H1N1) Russian influenza strain were prepared and evaluated in adult doubly seronegative volunteers at several doses. The recombinants derived from both donor viruses were attenuated for the doubly seronegative adults. Less than 5% of infected vaccinees developed a febrile or systemic reaction, whereas five of six recipients of wild-type virus developed such a response. The 50% human infectious dose (HID(50)) for each recombinant was approximately 10(5.0) 50% tissue culture infective doses. The virus shed by the ts-1A2 and ca vaccinees retained the ts or ca phenotype, or both. This occurred despite replication of the recombinant viruses for up to 9 days. No evidence for transmission of the ca or ts-1A2 recombinant virus to controls was observed. A serum hemagglutination inhibition response was detected in less than 50% of the infected vaccinees. However, with the more sensitive enzyme-linked immunosorbent assay, a serological response was detected in 100% of the ca vaccinees given 300 HID(50) and approximately 70% of ca or ts vaccinees who received 10 to 32 HID(50) of virus. These results indicate that the recombinants derived from both donor viruses were satisfactorily attenuated and were stable genetically after replication in doubly seronegative adults although they induced a lower serum hemagglutination inhibition response than that found previously for H3N2 ts and ca recombinants.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7216417      PMCID: PMC551124          DOI: 10.1128/iai.29.2.348-355.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Influenza A viruses; laboratory studies, with special reference to European outbreak of 1950-1.

Authors:  A ISAACS; A W GLEDHILL; C H ANDREWES
Journal:  Bull World Health Organ       Date:  1952       Impact factor: 9.408

2.  A placebo-controlled dose-response study of the reactogenicity and immunogenicity of a cold-adapted recombinant A/Victoria/3/75 (H3N2) live influenza virus candidate vaccine in healthy volunteers.

Authors:  A Hrabar; I Vodopija; F E André; J R Mitchell; H F Maassab; A V Hennessy; F M Davenport
Journal:  Dev Biol Stand       Date:  1977 Jun 1-3

3.  Temperature-sensitive mutants of influenza A virus: evaluation of the A/Victoria/75-ts-1A2 temperature-sensitive recombinant virus in seronegative adult volunteers.

Authors:  B R Murphy; R M Chanock; M M Levine; G A van Blerk; E J Berquist; R G Douglas; R F Betts; R B Couch; T R Cate
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

4.  Temperature-sensitive mutants of influenza virus. Identification of the loci of the two ts lesions in the Udorn-ts-1A2 donor virus and the correlation of the presence of these two ts lesions with a predictable level of attenuation.

Authors:  J G Massicot; B R Murphy; F Thierry; L Markoff; K Y Huang; R M Chanock
Journal:  Virology       Date:  1980-02       Impact factor: 3.616

5.  Temperature-sensitive mutants of influenza A virus: evaluation of A/Victoria/3/75-ts-1[E] recombinant viruses in volunteers.

Authors:  B R Murphy; L J Markoff; N T Hosier; H M Rusten; R M Chanock; A P Kendal; R G Douglas; R F Betts; T R Cate; R B Couch; M M Levine; D H Waterman; H P Holley
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

6.  Cold adapted variants of influenza A. II. Comparison of the genetic and biological properties of ts mutants and recombinants of the cold adapted A/AA/6/60 strain.

Authors:  S B Spring; H F Maassab; A P Kendal; B R Murphy; R M Chanock
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

7.  Temperature-sensitive mutants of influenza A virus. XII. Safety, antigenicity, transmissibility, and efficacy of influenza A/Udorn/72-ts-1[E] recombinant viruses in human adults.

Authors:  D D Richman; B R Murphy; R M Chanock; J M Gwaltney; R G Douglas; R F Betts; N R Blacklow; F B Rose; T A Parrino; M M Levine; E S Caplan
Journal:  J Infect Dis       Date:  1976-12       Impact factor: 5.226

8.  Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain.

Authors:  B R Murphy; H P Holley; E J Berquist; M M Levine; S B Spring; H F Maassab; A P Kendal; R M Chanock
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

9.  Use of the enzyme-linked immunosorbent assay to detect serum antibody responses of volunteers who received attenuated influenza A virus vaccines.

Authors:  B R Murphy; E L Tierney; B A Barbour; R H Yolken; D W Alling; H P Holley; R E Mayner; R M Chanock
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

10.  Genetic approaches to attenuation of influenza A viruses for man.

Authors:  B R Murphy; L J Markoff; R M Chanock; S B Spring; H F Maassab; A P Kendal; N J Cox; M M Levine; R G Douglas; R F Betts; R B Couch; T R Cate
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1980-02-25       Impact factor: 6.237

View more
  45 in total

1.  In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory.

Authors:  D C Powers; L F Fries; B R Murphy; B Thumar; M L Clements
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  Evaluation of bovine, cold-adapted human, and wild-type human parainfluenza type 3 viruses in adult volunteers and in chimpanzees.

Authors:  M L Clements; R B Belshe; J King; F Newman; T U Westblom; E L Tierney; W T London; B R Murphy
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

3.  Quantitative modeling of virus evolutionary dynamics and adaptation in serial passages using empirically inferred fitness landscapes.

Authors:  Hyung Jun Woo; Jaques Reifman
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

4.  Attenuation of wild-type human influenza A virus by acquisition of the PA polymerase and matrix protein genes of influenza A/Ann Arbor/6/60 cold-adapted donor virus.

Authors:  M H Snyder; M L Clements; D De Borde; H F Maassab; B R Murphy
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

5.  Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses.

Authors:  B R Murphy; M A Phelan; D L Nelson; R Yarchoan; E L Tierney; D W Alling; R M Chanock
Journal:  J Clin Microbiol       Date:  1981-03       Impact factor: 5.948

6.  Evaluation of A/Alaska/6/77 (H3N2) cold-adapted recombinant viruses derived from A/Ann Arbor/6/60 cold-adapted donor virus in adult seronegative volunteers.

Authors:  B R Murphy; R M Chanock; M L Clements; W C Anthony; A J Sear; L A Cisneros; M B Rennels; E H Miller; R E Black; M M Levine; R F Betts; R G Douglas; H F Maassab; N J Cox; A P Kendal
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

7.  Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers.

Authors:  N Yamane; Y Nakamura; M Yuki; T Odagiri; N Ishida
Journal:  J Hyg (Lond)       Date:  1984-04

8.  Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild-type influenza infection in humans.

Authors:  J S Youngner; J J Treanor; R F Betts; P Whitaker-Dowling
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

9.  A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults.

Authors:  Ruth A Karron; Karen Callahan; Catherine Luke; Bhagvanji Thumar; Josephine McAuliffe; Elizabeth Schappell; Tomy Joseph; Kathleen Coelingh; Hong Jin; George Kemble; Brian R Murphy; Kanta Subbarao
Journal:  J Infect Dis       Date:  2009-03-01       Impact factor: 5.226

10.  FluTE, a publicly available stochastic influenza epidemic simulation model.

Authors:  Dennis L Chao; M Elizabeth Halloran; Valerie J Obenchain; Ira M Longini
Journal:  PLoS Comput Biol       Date:  2010-01-29       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.